My mother was making lunch when she heard a thump from the bedroom. She ran upstairs and found my father face down on the carpet, blood seeping from a gash under his eye. He had been lightheaded and exhausted since a chemo session at Memorial Sloan Kettering; sitting on the edge of the bed, everything had gone black. As she struggled to lift him, he vowed he was done—done with Western doctors, whom he called “crooks” and “quacks”; done with the poisons coursing through his body; done with treatments he didn’t believe in. That evening, with a bruised eye and stiff neck, he booked a flight to Arizona to visit Envita Medical Centers, a clinic he had found online. Its website promised a “proprietary” chemotherapy so gentle that patients could hike and exercise, plus testimonials from people who claimed to have beaten aggressive cancers. My father, Rajeev, 63, believed this outpatient clinic, at nearly $10,000 a week, could save him from Stage 4 lung cancer. His distrust of medicine was lifelong. The son of an Indian homeopath who warned that vaccines were dangerous and American children overmedicated, and an entrepreneur who had spent years helping doctors submit insurance claims, he saw modern medicine as cold, costly and callous. My mother, brother and I begged him to stay at Sloan Kettering, but he was transfixed by online stories of miracle recoveries. He would rather spend his money at Envita, he said, than line the pockets of a pharmaceutical industry that made billions from cancer. At the time, I saw his choice as an extreme personal quirk. Only later did I understand it as a preview of a distrust that was about to go mainstream.
Long before the crisis, my dad had ignored warning signs. In early 2019, a heart scan revealed a concerning lung nodule and interstitial lung disease. The doctor called on a Saturday morning, imploring him to get it checked, but my dad, a smoker for forty years with no symptoms, dismissed it as hysteria. By summer, he had a dry cough and shortness of breath. Instead of seeing a pulmonologist, he turned to the family homeopath, who suggested castor oil, carbo vegetabilis, elderberry syrup and mouth taping. His symptoms only worsened. By September, a bronchoscopy revealed adenocarcinoma; the cancer had already spread to his brain. In the car home, he texted the homeopath asking for alternative clinics “before I go down the usual road of treatment.” His oncologist offered chemotherapy designed to preserve quality of life, but couldn’t tell him how long he had. “Prognosis?” his best friend texted. “Death. Eventually,” he answered. “Drugs drugs and more drugs for now.” Every appointment became a volcanic fight at home. During one teary argument, my brother said, “I think you’re just saying that you’re scared.” “Yes,” my dad said. “I’m scared shitless.” We got him through one round of chemo, but online ads for spa-like clinics, vitamin infusions and “nontoxic” therapies kept pulling at him. Researchers have found that alternative clinics deliberately target cancer patients searching for survival rates and chemo side effects. My dad was drawn into that world quickly, but Envita, in Scottsdale, Arizona, was the one he became most taken with.
When we arrived, my dad—his face still bruised from the fall—said the city felt like somewhere he could heal. Envita was in an unassuming office park, with natural light, wood floors, leather couches and cheerful receptionists. A naturopathic provider sat with us for a nearly four-hour consultation. He explained that Envita was integrative, combining conventional cancer therapies with alternative ones. He drew diagrams of a “proprietary” chemotherapy regimen using insulin and low-dose chemo, promising minimal side effects. He described a cell therapy in Mexico, costing $125,000, that would train my dad’s body to fight cancer. There were also “supportive” therapies: hydrogen peroxide infusions, ozone in the blood, coffee enemas. I don’t remember hearing about risks. I remember feeling hope. After the consultation, I told my dad he should commit. I texted my brother that I was “pretty sold.” I sent a voice memo to my best friend saying I felt “good and supported and trusting” for the first time. At his first treatment, he signed the thick stack of forms without reading them. “Who knows what I’m signing,” he laughed, and handed the receptionist two credit cards. In the infusion room, patients sat in leather recliners with IVs. Over the next weeks, a rhythm developed. My parents went to Envita every day; when he felt well enough, they sat in the sun at a nearby park. Ten of his closest friends visited for a weekend. I visited every few weeks and was pleasantly surprised by how much better he looked. His breath improved, his cough softened, and large doses of steroids boosted his energy. Most important, he finally believed in his treatment. He had confidence, support, hope—things that can have a real effect on the body. He texted a former coworker that he would be “cancer free” by the end of February. “I’m fully intending to recover!” he wrote.
Shortly before Christmas, Envita flew my dad to Hermosillo, Mexico, for the first part of his cell therapy, a treatment not authorized in the United States. Over two days, he sat hooked to an IV while his cells were supposedly extracted and trained to destroy his cancer. He called them “my little Pac-Mans.” But after he returned to Arizona, things unraveled. His shortness of breath returned, his appetite vanished, his nose bled, his body shook with chills. He lost twenty more pounds on top of the twenty-four he’d already lost, and sitting on a chair without a cushion was painful. His hair fell out so quickly that he shaved it off. Photos from that time are hard to look at: a skeletal face, sunken eyes, shoulder bones protruding through his sweater. Privately, he told his best friend he knew he was dying, but every day he went back to Envita, clinging to hope. The costs were staggering—around $200,000 since moving to Arizona, not counting supplements and outside scans. In January, Envita told him there were signs of improvement in his lungs and that his brain lesions were disappearing. But the man we saw was wasting away. My mother begged him to return to Sloan Kettering; he refused, insisting the treatments were “running their course.” Then a fellow patient told him about fenbendazole, a dog dewormer that had gone viral online. He found a blog claiming a miraculous cure for Stage 4 lung cancer, ordered the powder on Amazon, and mixed it into yogurt. A few days later, his oxygen level dipped dangerously low. He refused to let my mom call an ambulance. “Please, Rajeev,” she said, “you are going to die on this couch.” She called 911 anyway.
I arrived in Scottsdale that evening and went straight to the hospital, where my dad was breathing through an oxygen mask in the ICU. A doctor asked where he was being treated; when I told him Envita, he wasn’t surprised. He said they received patients from such clinics all the time, “like this.” Then he gestured at my father gasping for air. “You wasted your money.” At the time, I thought he was callous. But later I learned how much history Envita had with regulators. The clinic was founded in 2001 by Santo Dino Prato, who once said he had a “God-given gift.” In 2006, the FDA sent Envita a warning letter for providing unauthorized cell therapy; the clinic sidestepped U.S. regulators by doing that therapy in Mexico. A 2015 FDA criminal investigation report detailed “questionable activity,” including selling expensive treatments to desperate patients and administering unapproved drugs to end-stage cancer patients. But the case was closed because the U.S. attorney’s office in Phoenix wasn’t interested. A doctor at Envita later had his license temporarily suspended for gross negligence; a patient who woke up paralyzed after a procedure sued the clinic, accusing it of creating a “false impression” of superior care; the case was settled. Envita defended itself, saying it doesn’t guarantee outcomes and that patients sign consent forms. There are dozens of similar clinics, I found, operating in a patchwork of state regulations, often charging families enormous amounts for unproven therapies. When I shared my dad’s Envita records with oncologists, they were stunned. One said he struggled “to identify a biologically plausible rationale” for the treatment plan. Another wrote in all caps: “OH DEAR.” My dad’s original Sloan Kettering oncologist, Dr. Mark Kris, told me that sticking with conventional chemo might have improved his quality of life, but his chance of long-term survival was slim. He couldn’t promise my dad his life back. “The only thing worse than no hope,” he said, “is false hope.”
In the ICU, we tried desperately to get my dad back to New Jersey, but he was too fragile, barely able to breathe on his own. After he was intubated, tests showed the cancer had progressed significantly. After nearly a week, my mother, brother and I decided to pull him from the breathing machine. Doctors said he would last thirty, maybe sixty minutes. But he held on, and family poured into a large, sunny room to say goodbye. We shared stories while he lay under morphine. Then, suddenly, he gasped: “Dog! Yogurt!”—a breathless demand for the fenbendazole powder. We told him the cancer had spread too far; the powder was not going to save him. The more we refused, the more indignant he became. “You’re killing me!” he croaked. We asked everyone to leave. And then, instead of sitting at my father’s bedside while he was still alert, instead of saying everything I’d wanted to say—that I loved him, that I would look for him in the birds—I walked to the grocery store to buy yogurt. When I returned, my mom spoon-fed him the yellow powder; it stained his white goatee. He hung on for another day, barely conscious, waiting for a miracle. That night I heard him rustle and went to his bedside. “I don’t think I’m going to make it, Trishi,” he whispered. “It’s OK,” I said gently, careful not to wake my mom. “We will be OK.” By the next afternoon, he was gone—no miracle, no secret cure, just precious final moments lost to something he read online. Looking back, I realize how many conversations about his illness were about what he could or should do. We never talked about what he actually wanted from the time he had left. There seemed to be only two options: treatment at any cost or death. Acceptance never crossed our minds. My father’s story is not just one man’s eccentricity; it’s a preview of a broader crisis. Patients today are inundated with misinformation and unproven therapies, and many choose them because they hunger for personalized, empathetic care, for someone who looks them in the eye and promises they’ll be OK. I know that feeling. I felt it in that sunny Scottsdale clinic, and I would have done almost anything to keep it. But false hope is a ghost that takes everything. My father died chasing it, surrounded by a family that loved him—and with a question that will haunt me forever: What if we had simply allowed him to be afraid, and held his hand? I still look for him in birds. I still wish I had stayed by his side instead of going for yogurt. But all I can do now is tell the truth about what happened, in the hope that someone else might hear it before it’s too late.